Advertisement
BSX vs MMSI
Which Stock Would AI Choose? Boston Scientific (BSX) vs. Merit Medical Systems (MMSI) Stock Comparison
Key Takeaways
- Boston Scientific (BSX) commands a market capitalization of approximately $90.6 billion, dwarfing Merit Medical Systems' (MMSI) $4.2 billion, highlighting significant scale differences.
- Recent quarterly revenue growth stands at about 16% for BSX versus 10.9% for MMSI, underscoring BSX's faster expansion.
- Both stocks have traded near multi-month lows in recent market activity, with BSX down sharply year-to-date while MMSI shows modest recent gains.
- Analyst price targets imply over 50% upside for BSX (average $96.66) and around 40% for MMSI ($99), signaling optimism for both.
- Upcoming quarterly earnings for both companies could serve as key catalysts, with BSX reporting first on April 22.
Introduction
Comparing Boston Scientific (BSX) and Merit Medical Systems (MMSI) offers insights into the medical devices sector, where innovation drives growth amid regulatory and economic pressures. Both companies specialize in cardiovascular and interventional products, appealing to investors seeking exposure to healthcare technology. Traders focused on relative performance, upcoming earnings, and sector momentum will find this analysis valuable for assessing trade-offs in scale, growth rates, and recent market positioning.
BSX Overview and Recent Performance
Boston Scientific Corporation (BSX) is a global leader in medical devices, with key franchises in cardiology, endoscopy, and neuromodulation. The company reported robust full-year 2025 revenue of $16.75 billion, up 17.6% from prior year, driven by strong demand in cardiovascular procedures. In recent market activity, shares have declined sharply, trading near the 52-week low of $60.59 amid broader sector pressures and cautious 2026 guidance issued earlier in the year. Sentiment has been tempered by analyst price target adjustments ahead of Q1 earnings, though expectations remain for 11% revenue growth to $5.19 billion. Key influences include competitive dynamics and macroeconomic factors affecting procedure volumes.
MMSI Overview and Recent Performance
Merit Medical Systems, Inc. (MMSI) develops and manufactures devices for cardiology, radiology, and peripheral interventions, serving hospitals and clinics worldwide. Trailing twelve-month revenue reached $1.52 billion, with Q4 2025 sales up 10.9% year-over-year, reflecting steady demand in core markets. Shares have shown relative stability in recent weeks, posting modest gains around $70 despite post-earnings pullbacks, buoyed by revenue recasting to emphasize therapies growth. Upcoming Q1 results on April 30 are anticipated to highlight continued execution, with influences including supply chain resilience and product expansions like partnerships with Medtronic.
Trending AI Robots
Tickeron’s Trending AI Robots page curates 25 top-performing bots from over 350 AI trading systems that analyze thousands of tickers across stocks, ETFs, and crypto. These bots employ diverse strategies—such as trend following, scalping, and sector rotation—over timeframes from 5 minutes to 60 days, showcasing annualized returns ranging from 15% to 168%, win rates of 54% to 88%, and profit factors up to 11.7. Examples include semiconductor-focused agents with 65-75% win rates and multi-sector portfolios exceeding 100% returns. This dynamic selection adapts to current conditions, spotlighting high-conviction opportunities. Explore the page to identify bots aligning with your trading style.
Head-to-Head Comparison
Both BSX and MMSI operate in the competitive medical devices space, emphasizing minimally invasive solutions, but differ markedly in scale and diversification. BSX’s broader portfolio spans multiple therapeutic areas, fueling higher revenue growth (17%+ annually) versus MMSI’s focused interventional niche (11% growth). Recent momentum favors MMSI’s steadier trading amid BSX’s volatility near lows. Risk profiles reflect size: BSX faces greater exposure to regulatory hurdles and M&A (mergers and acquisitions) integration, while MMSI contends with concentration risks. Market sentiment leans positive for both, with similar forward P/E ratios around 30-33, though BSX offers superior long-term catalysts via innovation pipeline.
Tickeron AI Verdict
Tickeron’s AI tools, evaluating trend consistency, volume patterns, and relative strength, would likely favor BSX in the current environment. Despite recent pullbacks, BSX’s scale, superior growth trajectory, and substantial analyst upside (over 50%) position it ahead probabilistically, particularly with near-term earnings potentially reigniting momentum. MMSI remains a solid contender for stability-focused strategies.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a StrongBuy and MMSI is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BSX’s FA Score shows that 0 FA rating(s) are green whileMMSI’s FA Score has 0 green FA rating(s).
- BSX’s FA Score: 0 green, 5 red.
- MMSI’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BSX’s TA Score shows that 4 TA indicator(s) are bullish while MMSI’s TA Score has 6 bullish TA indicator(s).
- BSX’s TA Score: 4 bullish, 4 bearish.
- MMSI’s TA Score: 6 bullish, 3 bearish.
Price Growth
BSX (@Medical/Nursing Services) experienced а -5.20% price change this week, while MMSI (@Pharmaceuticals: Other) price change was -0.61% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.03%. For the same industry, the average monthly price growth was -3.62%, and the average quarterly price growth was -16.07%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.83%. For the same industry, the average monthly price growth was -0.55%, and the average quarterly price growth was -14.44%.
Reported Earning Dates
BSX is expected to report earnings on Jul 29, 2026.
MMSI is expected to report earnings on Jul 29, 2026.
Industries' Descriptions
@Medical/Nursing Services (+0.03% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (-1.83% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| BSX | MMSI | BSX / MMSI | |
| Capitalization | 65.9B | 3.97B | 1,660% |
| EBITDA | 5.49B | 349M | 1,574% |
| Gain YTD | -53.508 | -24.512 | 218% |
| P/E Ratio | 18.55 | 28.68 | 65% |
| Revenue | 20.6B | 1.54B | 1,336% |
| Total Cash | 1.45B | 488M | 298% |
| Total Debt | 11B | 822M | 1,338% |
BSX | MMSI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 52 | 16 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 59 Fair valued | 71 Overvalued | |
PROFIT vs RISK RATING 1..100 | 97 | 94 | |
SMR RATING 1..100 | 58 | 75 | |
PRICE GROWTH RATING 1..100 | 66 | 61 | |
P/E GROWTH RATING 1..100 | 98 | 85 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BSX's Valuation (59) in the Medical Specialties industry is in the same range as MMSI (71). This means that BSX’s stock grew similarly to MMSI’s over the last 12 months.
MMSI's Profit vs Risk Rating (94) in the Medical Specialties industry is in the same range as BSX (97). This means that MMSI’s stock grew similarly to BSX’s over the last 12 months.
BSX's SMR Rating (58) in the Medical Specialties industry is in the same range as MMSI (75). This means that BSX’s stock grew similarly to MMSI’s over the last 12 months.
MMSI's Price Growth Rating (61) in the Medical Specialties industry is in the same range as BSX (66). This means that MMSI’s stock grew similarly to BSX’s over the last 12 months.
MMSI's P/E Growth Rating (85) in the Medical Specialties industry is in the same range as BSX (98). This means that MMSI’s stock grew similarly to BSX’s over the last 12 months.
| BSX | MMSI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 68% | N/A |
| Stochastic ODDS (%) | 2 days ago 60% | 2 days ago 59% |
| Momentum ODDS (%) | 2 days ago 49% | 2 days ago 59% |
| MACD ODDS (%) | 2 days ago 57% | 6 days ago 61% |
| TrendWeek ODDS (%) | 2 days ago 54% | 2 days ago 59% |
| TrendMonth ODDS (%) | 2 days ago 59% | 2 days ago 56% |
| Advances ODDS (%) | 15 days ago 57% | 8 days ago 64% |
| Declines ODDS (%) | 9 days ago 54% | 12 days ago 58% |
| BollingerBands ODDS (%) | 2 days ago 79% | 2 days ago 56% |
| Aroon ODDS (%) | 2 days ago 68% | 2 days ago 46% |
Advertisement
MMSI and
Correlation & Price change
A.I.dvisor indicates that over the last year, MMSI has been loosely correlated with BSX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if MMSI jumps, then BSX could also see price increases.
| Ticker / NAME | Correlation To MMSI | 1D Price Change % | ||
|---|---|---|---|---|
| MMSI | 100% | -1.02% | ||
| BSX - MMSI | 56% Loosely correlated | -2.12% | ||
| ICUI - MMSI | 52% Loosely correlated | -3.01% | ||
| SYK - MMSI | 50% Loosely correlated | -1.01% | ||
| A - MMSI | 43% Loosely correlated | -0.45% | ||
| MASI - MMSI | 43% Loosely correlated | N/A | ||
More | ||||